State agencies in New Mexico experienced significant delays during their initial rollout of opioid settlement funds, returning roughly a quarter of their allocated money in fiscal year 2024 before substantially improving their distribution rates in subsequent years, according to a recent review published by the New Mexico State Auditor’s Office.
The comprehensive evaluation, released by State Auditor Joseph Maestas, examined how seven state entities managed and spent approximately $54 million in legal settlement funds distributed across three consecutive fiscal years. The findings reveal a marked contrast between early bureaucratic bottlenecks and subsequent operational success in putting the critical resources to work.
During the 2024 fiscal cycle, which spanned from July 1, 2023, through June 30, 2024, the state agencies under review were unable to spend more than $5 million of the $21 million distributed to them. Because the public entities could not deploy nearly 24 percent of the resources within the mandated regulatory timeframes, the unexpended balances had to be returned.
Among the state departments evaluated, the New Mexico Children, Youth and Families Department exhibited the most pronounced shortfall. The child welfare department was designated to receive $2 million in fiscal year 2024 specifically to improve monitoring systems and support adherence plans for households caring for infants who had been exposed to opioids.
According to the state auditor’s findings, the Children, Youth and Families Department failed to utilize any portion of its $2 million allocation during that initial fiscal year. The report further noted that the department did not provide an explanation to the auditor’s office regarding why the funds went completely untouched, and agency representatives did not respond to subsequent inquiries seeking clarification on the matter.
The stakes surrounding the prompt deployment of these funds are particularly high for New Mexico, where the consequences of the addiction crisis have been severe and enduring. For the vast majority of the past two decades, the state has recorded some of the highest fatal drug overdose rates in the United States, placing intense pressure on state programs to deliver immediate relief.
The money analyzed in the audit represents an early portion of more than $920 million that New Mexico is ultimately slated to receive from nationwide legal settlements. These multi-million-dollar payouts began arriving in 2023 following extensive litigation against prescription opioid manufacturers, pharmaceutical distributors, and retail pharmacy chains accused of fueling and intensifying the widespread overdose crisis.
Under the overall distribution framework established for the state's legal recovery, local municipal and county governments are slated to receive more than $344 million, while state-level agencies are designated to receive an aggregate total exceeding $328 million to fund remediation and treatment initiatives.
The funding directed to state agencies was intended to support a broad array of public health, social, and clinical services designed to mitigate the harms of opioid dependence. Various departments were tasked with deploying targeted programs to address both prevention and recovery throughout different sectors of the population.
Among the participating entities, the Health Care Authority received resources to finance vital support mechanisms, including housing assistance programs, expanded telehealth services, and the operation of community-based behavioral health clinics. Concurrently, the state Health Department and the Corrections Department received allocations to distribute overdose reversal medications to underserved rural regions and supply opioid replacement therapies within state correctional facilities.
In analyzing the initial underspending, the auditor's report highlighted the steep administrative hurdles that agencies confronted during the opening phase of the funding lifecycle. Many of the departments were attempting to launch brand-new initiatives that required recruiting specialized personnel, navigating complex procurement contracts, building inter-agency partnerships, and establishing community service capacity from scratch.
Following those early administrative setbacks, state agencies and the University of New Mexico demonstrated a dramatic turnaround in their spending efficiency. Over the course of fiscal years 2025 and 2026, the participating public entities successfully expended all but roughly 1 percent of the approximately $32 million in settlement funding they received.
Auditor Maestas characterized the turnaround as an encouraging sign that state administrative bodies have developed the necessary infrastructure to manage the settlement revenues effectively. He noted that the data from 2025 and 2026 indicates that state agencies are actively learning, adapting their internal procedures, and improving their capacity to deploy settlement funds into local communities.
The assessment of state agencies represents the second oversight report regarding opioid settlement revenue issued by the State Auditor's Office in recent weeks. An earlier inquiry focused on local municipal and county governments, revealing that nearly half of those local entities had failed to report any spending of their allocated opioid settlement dollars by July of the prior year.
(0)